Potential Drug Delivery Approaches for XFS-associated and XFS-associated Glaucoma
Authors:
- Uday B. KompellaUKUday B. Kompella
- 1 January 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 23, S77-S79
Abstract
Key tissue targets in treating exfoliation syndrome (XFS) and the associated glaucoma include lens, iris, and ciliary body, which produce the exfoliative material, and the trabecular meshwork, which may be impaired by the exfoliative material. In addition to antiglaucoma drug therapy, strategies for treating the disease include approaches for preventing formation of exfoliative material as well as those aimed at digesting exfoliative material. A variety of drug molecules including small molecules, protein drugs, and nucleic acids are potential candidates for treating XFS. Potential drug classes include antioxidants, lysyl oxidase-like 1 enhancers, antifibrotics, anti-inflammatory agents, proteases, and chaperones. However, the delivery of these agents to the target tissues in the anterior segment is hindered by protective static and dynamic barriers of the eye. Thus, unique drug delivery approaches are needed for each drug type (small molecules, proteins, and nucleic acids). In addition, there is a need for sustaining drug therapy for treating XFS, which can potentially be addressed by using nanoparticles, microparticles, implants, and contact lens delivery systems. This article provides an overview of drug delivery challenges and opportunities in treating XFS with the focus being on nanomedicines.Keywords
This publication has 17 references indexed in Scilit:
- Exfoliation syndromeCurrent Opinion in Ophthalmology, 2013
- Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lensesJournal of Controlled Release, 2013
- Pseudoexfoliation syndrome, a systemic disorder with ocular manifestationsHuman Genomics, 2012
- Neue pathogenetische Erkenntnisse zum Pseudoexfoliations-Syndrom/GlaukomDer Ophthalmologe, 2012
- Interfacial Interaction between Transmembrane Ocular Mucins and Adhesive Polymers and Dendrimers Analyzed by Surface Plasmon ResonancePharmaceutical Research, 2012
- Natural History of Open-Angle GlaucomaOphthalmology, 2009
- Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNVGene Therapy, 2009
- Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrinsInternational Journal of Pharmaceutics, 2005
- Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamideJournal of Controlled Release, 2005
- Pseudoexfoliation syndrome for the comprehensive ophthalmologist Intraocular and systemic manifestationsHistorical imageOphthalmology, 1998